封面
市場調查報告書
商品編碼
1268874

微生物組測序服務市場規模、份額、趨勢分析報告、技術(合成測序、連接測序、Sanger測序)、應用、用途、地區、細分趨勢,2023-2030

Microbiome Sequencing Services Market Size, Share & Trends Analysis Report By Technology (Sequencing By Synthesis, Sequencing By Ligation, Sanger Sequencing), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

微生物組測序服務市場增長和趨勢:

根據 Grand View Research, Inc. 的最新報告,全球微生物組測序服務市場預計到 2030 年將達到 31 億美元。

由於全球投資和基因組研究的增加,預計從 2023 年到 2030 年,該市場將以 10.9% 的複合年增長率增長。 例如,2022 年 10 月,丹麥微生物組研究公司 Clinical Microbiomics 宣布風險投資公司 Sev□□enture Partners 已向該公司投資 1000 萬歐元(約合 970 萬美元)。 Clinical Microbiomics 將使用這筆資金來推進其係統生物學和微生物組分析平台,擴展其多組學數據集成服務範圍,並從美國開始進行國際擴張。計劃於 由於研發中不斷增加的基因組努力,微生物組測序服務的市場正在擴大。

近年來,對微生物組測序的研究取得了顯著進展,越來越多的證據表明微生物組對人類健康具有深遠影響。 測序儀技術的巨大進步和服務成本的大幅降低使得開展研究以調查存在於人體內外的各種微生物變得更加容易。 此外,關於人體微生物如何影響人體生理的研究正在取得進展,針對癌症、精神疾病、自身免疫性疾病、傳染病等多種疾病的治療和預防新方法正在開發中,具有巨大的發展潛力。 對微生物組的日益增長的研究預計將推動對微生物組測序服務的需求。

COVID-19 大流行正在對微生物組測序服務市場產生積極影響。 微生物組測序主要用於傳染病和癌症領域。 病毒的存在和宿主對 COVID-19 的反應可以通過 RNA 測序來揭示。 因此,支撐 2020 年後發展的主要因素之一是在 COVID-19 大流行期間微生物組測序工具的採用增加。

此外,政府與行業參與者合作開展的廣泛病毒研究也推動了大流行期間對微生物組測序的高需求。 例如,2020 年 3 月,英國建立了基因組測序合作夥伴關係,以促進對 COVID-19 陽性患者樣本進行快速、全面和詳盡的測序。 該網絡旨在對該病毒的所有陽性患者樣本進行測序。 Oxford Nanopore 很高興支持在英國開展這項計劃的團隊。

微生物組測序服務市場報告要點:

  • 合成測序部分預計在 2022 年佔據最大份額 57.5%,並在預測期內以有利的複合年增長率增長。 這是由於合成測序方法允許同時對數百萬個擴增子進行測序的高度並行性,導致人們對研究細菌群落的興趣顯著增加。
  • 按應用劃分,胃腸道疾病領域將佔 2022 年市場的最大份額,達到 54.0%。 這可能是由於胃腸道疾病的高發病率以及與腸道微生物群和益生菌使用相關的意識不斷增強。
  • 按最終用途劃分,學術研究機構部分在 2022 年所佔份額最大,為 43.3%。 用於蛋白質和小分子分析的微生物組測序服務在研究和學術機構中的廣泛應用有助於該領域的高市場份額。
  • 到 2022 年,北美將佔據 47.85% 的最大市場份額。 這種按地區劃分的高市場份額主要是由於在微生物組測序服務中越來越多地使用極其先進的技術和系統,以及基因組研究技術發展的進步。 此外,由於在微生物組測序服務中越來越多地採用技術先進的方法和平台以及基因組研究的技術進步,預計北美市場將發展得更快。

內容

第 1 章調查方法及範圍

  • 資訊採購
  • 資訊或數據分析
  • 市場範圍和細分定義
  • 市場模型
    • 按公司市場份額進行的市場調查
    • 區域分析

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場體系展望
    • 母公司市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場促進因素分析
      • 增加基因組調查並擴大微生物組測序的應用
      • 增加對採用下一代測序的投資
      • 慢性病患病率上升和對微生物組測序的需求
    • 市場抑制因素分析
      • 缺乏微生物組序列數據分析方面的專業知識和熟練的專業人員
  • 行業分析工具
    • SWOT 分析;按因素(政治/法律、經濟/技術)
    • 波特的五力分析
    • 2022 年採用率和增長前景圖
  • 分析 COVID-19 感染的影響

第 4 章微生物組測序服務市場:技術業務分析

  • 微生物組測序服務市場:技術市場份額分析
  • 按技術
  • 合成測序
  • 連接測序
  • 桑格測序
  • 其他

第 5 章微生物組測序服務市場:應用業務分析

  • 微生物組測序服務市場:應用市場份額分析
  • 通過使用
  • 自身免疫性疾病
  • 癌症
  • 胃腸道疾病
  • 其他用途

第 6 章微生物組測序服務市場:最終用戶業務分析

  • 微生物組測序服務市場:最終用戶市場份額分析
  • 按最終用途
  • 製藥和生物技術公司
  • 學術研究機構
  • 其他最終用戶

第 7 章微生物組測序服務市場:區域業務分析

  • 2022 年和 2030 年按地區劃分的微生物組測序服務市場份額
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 8 章競爭格局

  • 公司分類
  • 戰略規劃
  • 公司簡介/名單
    • Microbiome Insights Inc.
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • Baseclear BV
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • Clinical-Microbiomics A/S
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • Merieux NutriSciences Corporation
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • MR DNA
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • Metabiomics Corp.
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • Rancho BioSciences
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • Second Genome
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • Zymo Research Corporation
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
    • uBiome, Inc.
      • 概覽
      • 財務業績(淨收入/銷售額/EBITDA/毛利率)
      • 技術基準
      • 戰略舉措
Product Code: GVR-4-68040-059-8

Microbiome Sequencing Services Market Growth & Trends:

The global microbiome sequencing services market size is projected to reach USD 3.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.9% from 2023 to 2030, as a result of rising investment and an increase in genomic research globally. For instance, in October 2022, Danish microbiome research comp1any, Clinical Microbiomics announced that venture capital firm Seventure Partners had invested €10 million ($9.7 million) in the company. The funds will be used by Clinical Microbiomics to advance the systems biology and microbiome profiling platforms, as well as to broaden the scope of their service offerings for multi-omics data integration and extend their reach internationally, starting with the US. Due to a large number of genomic initiatives for research and development, the market for microbiome sequencing services is growing.

With growing evidence that microbiomes have a significant effect on human health, the research on microbiome sequencing has advanced considerably in recent years. Studies investigating the variety of microbes that exist on and inside human bodies are now possible easily since there have been major improvements in sequencing technologies and significant declines in the costs of services. Furthermore, growing research on how the human body's microbiome influences certain aspects of human physiology provides enormous potential for the development of novel treatments and preventative measures for a wide range of diseases including cancer, mental health disorders, autoimmune conditions, and infectious diseases. This growing research on the microbiome is expected to drive the demand for microbiome sequencing services.

The COVID-19 pandemic has had positive effects on the market for microbiome sequencing services. Microbiome sequencing is mainly employed in the fields of infectious disease and cancer. The existence of the virus and the host's reaction to COVID-19 may be determined through RNA sequencing. Therefore, one of the key factors supporting its development in 2020 and beyond was the increasing adoption of microbiome sequencing tools during the COVID-19 pandemic.

Moreover,the government's partnerships with industry participants for extensive virus research also fueled the pandemic's high demand for microbiome sequencing. For instance, the UK established a genome sequencing partnership in March 2020 to facilitate rapid, comprehensive, and exhaustive sequencing analysis of samples from patients who tested positive for COVID-19. The network seeks to sequence every positive patient sample for the virus. Oxford Nanopore is pleased to assist the teams working on this initiative in the UK

Microbiome Sequencing Services Market Report Highlights:

  • The sequencing by synthesis segment held the largest share of 57.5% in 2022 and is expected to expand at a lucrative CAGR during the forecast period. This is a result of the sequencing by synthesis method's highly parallel nature, which enables the simultaneous sequencing of millions of amplicons, which has greatly increased interest in the study of bacterial communities
  • By application, the gastrointestinal disorders segment accounted for the largest share of 54.0% in the market in 2022. This can be attributed to the high incidences of gastrointestinal disorders and growing awareness related to the gut microflora and the use of probiotics
  • By end-user, the academic research institutes segment held the largest share of 43.3% in 2022. The widespread application of microbiome sequencing services for protein, as well as small molecule analysis in research institutions and academics, contributes to the segment's high market share
  • North America held the largest market share of 47.85% in 2022. The high regional market share is largely due to the rise in the usage of extremely sophisticated techniques and systems in microbiome sequencing services and the technological developments made in genomic research studies. Furthermore, the market in North America is expected to develop more rapidly due to the increase in the adoption of technologically advanced methods and platforms in the microbiome sequencing services and advances in technology made in genomic research studies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increased genomic research and expanded uses for microbiome sequencing
      • 3.3.1.2. Increasing investments in next-generation sequencing adoption
      • 3.3.1.3. Rising prevalence of chronic diseases and need for microbiome sequencing
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Lack of expertise and skilled professionals for microbiome sequencing data analysis
  • 3.4. Industry Analysis Tools
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. Penetration and Growth Prospect Mapping, 2022
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Microbiome Sequencing Services Market: Technology Business Analysis

  • 4.1. Microbiome Sequencing Services Market: Technology Market Share Analysis
  • 4.2. Microbiome Sequencing Services Market Estimates & Forecast, By Technology (USD Million)
  • 4.3. Sequencing by synthesis
    • 4.3.1. Global Sequencing by synthesis Market, 2018 - 2030 (USD Million)
  • 4.4. Sequencing by ligation
    • 4.4.1. Global sequencing by ligation Market, 2018 - 2030 (USD Million)
  • 4.5. Sanger sequencing
    • 4.5.1. Global sanger sequencing Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Global other technology Market, 2018 - 2030 (USD Million)

Chapter 5. Microbiome Sequencing Services Market: Application Business Analysis

  • 5.1. Microbiome Sequencing Services Market: Application Market Share Analysis
  • 5.2. Microbiome Sequencing Services Market Estimates & Forecast, By Application (USD Million)
  • 5.3. Autoimmune Disorder
    • 5.3.1. Global autoimmune disorder Market, 2018 - 2030 (USD Million)
  • 5.4. Cancer
    • 5.4.1. Global cancer Market, 2018 - 2030 (USD Million)
  • 5.5. Gastrointestinal disorders
    • 5.5.1. Global gastrointestinal disorders Market, 2018 - 2030 (USD Million)
  • 5.6. Other applications
    • 5.6.1. Global other applications Market, 2018 - 2030 (USD Million)

Chapter 6. Microbiome Sequencing Services Market: End-User Business Analysis

  • 6.1. Microbiome Sequencing Services Market: End-User Market Share Analysis
  • 6.2. Microbiome Sequencing Services Market Estimates & Forecast, By End-User (USD Million)
  • 6.3. Pharmaceutical & Biotechnology Companies
    • 6.3.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.4. Academics research institutes
    • 6.4.1. Global academics research institutes Market, 2018 - 2030 (USD Million)
  • 6.5. Other end-users
    • 6.5.1. Global other end-users Market, 2018 - 2030 (USD Million)

Chapter 7. Microbiome Sequencing Services Market: Regional Business Analysis

  • 7.1. Microbiome Sequencing Services Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Argentina Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait Microbiome Sequencing Services Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Profiles/Listing
    • 8.3.1. Microbiome Insights Inc.
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.1.3. Technology Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Baseclear BV
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.2.3. Technology Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Clinical-Microbiomics A/S
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.3.3. Technology Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Merieux NutriSciences Corporation
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.4.3. Technology Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. MR DNA
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.5.3. Technology Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Metabiomics Corp.
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.6.3. Technology Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Rancho BioSciences
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.7.3. Technology Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Second Genome
      • 8.3.8.1. Overview
      • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.8.3. Technology Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Zymo Research Corporation
      • 8.3.9.1. Overview
      • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.9.3. Technology Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. uBiome, Inc.
      • 8.3.10.1. Overview
      • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.10.3. Technology Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 4 Global microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 5 Global microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 6 Global microbiome sequencing services market, by region, 2018 - 2030 (USD million)
  • Table 7 North America microbiome sequencing services market, by country, 2018 - 2030 (USD million)
  • Table 8 North America microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 9 North America microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 10 North America microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 11 U.S. microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 12 U.S. microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 13 U.S. microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 14 Canada microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 15 Canada microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 16 Canada microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 17 Europe microbiome sequencing services market, by country, 2018 - 2030 (USD million)
  • Table 18 Europe microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 19 Europe microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 20 Europe microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 21 UK microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 22 UK microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 23 UK microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 24 Germany microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 25 Germany microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 26 Germany microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 27 France microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 28 France microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 29 France microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 30 Italy microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 31 Italy microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 32 Italy microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 33 Spain microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 34 Spain microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 35 Spain microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 36 Denmark microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 37 Denmark microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 38 Denmark microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 39 Sweden microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 40 Sweden microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 41 Sweden microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 42 Norway microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 43 Norway microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 44 Norway microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 45 Asia Pacific microbiome sequencing services market, by country, 2018 - 2030 (USD million)
  • Table 46 Asia Pacific microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 47 Asia Pacific microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 48 Asia Pacific microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 49 Japan microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 50 Japan microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 51 Japan microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 52 China microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 53 China microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 54 China microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 55 India microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 56 India microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 57 India microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 58 Australia microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 59 Australia microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 60 Australia microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 61 Thailand microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 62 Thailand microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 63 Thailand microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 64 South Korea microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 65 South Korea microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 66 South Korea microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 67 Latin America microbiome sequencing services market, by country, 2018 - 2030 (USD million)
  • Table 68 Latin America microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 69 Latin America microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 70 Latin America microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 71 Brazil microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 72 Brazil microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 73 Brazil microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 74 Mexico microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 75 Mexico microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 76 Mexico microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 77 Argentina microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 78 Argentina microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 79 Argentina microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 80 Middle East & Africa microbiome sequencing services market, by country, 2018 - 2030 (USD million)
  • Table 81 Middle East & Africa microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 82 Middle East & Africa microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 83 Middle East & Africa microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 84 South Africa microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 85 South Africa microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 86 South Africa microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 87 Saudi Arabia microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 88 Saudi Arabia microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 89 Saudi Arabia microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 90 UAE microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 91 UAE microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 92 UAE microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 93 Kuwait microbiome sequencing services market, by technology, 2018 - 2030 (USD million)
  • Table 94 Kuwait microbiome sequencing services market, by application, 2018 - 2030 (USD million)
  • Table 95 Kuwait microbiome sequencing services market, by end-user, 2018 - 2030 (USD million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new products/services
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Microbiome sequencing services market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Microbiome sequencing services - Industry value chain analysis
  • Fig. 15 Microbiome sequencing services market driver analysis
  • Fig. 16 Microbiome sequencing services market restraint analysis
  • Fig. 17 Microbiome sequencing services market: Porter's analysis
  • Fig. 18 Microbiome sequencing services market: PESTLE analysis
  • Fig. 19 Microbiome sequencing services market: Technology outlook and key takeaways
  • Fig. 20 Microbiome sequencing services market: Technology market share analysis, 2022 - 2030
  • Fig. 21 Global sequencing by synthesis market, 2018 - 2030 (USD million)
  • Fig. 22 Global sequencing by ligation market, 2018 - 2030 (USD million)
  • Fig. 23 Global sanger sequencing market, 2018 - 2030 (USD million)
  • Fig. 24 Global other technology market, 2018 - 2030 (USD million)
  • Fig. 25 Microbiome sequencing services market: Application outlook and key takeaways
  • Fig. 26 Microbiome sequencing services market: Application market share analysis, 2022 - 2030
  • Fig. 27 Global autoimmune disorder market, 2018 - 2030 (USD million)
  • Fig. 28 Global cancer market, 2018 - 2030 (USD million)
  • Fig. 29 Global gastrointestinal disorders market, 2018 - 2030 (USD million)
  • Fig. 30 Global others applications market, 2018 - 2030 (USD million)
  • Fig. 31 Microbiome sequencing services market: End-user outlook and key takeaways
  • Fig. 32 Microbiome sequencing services market: End-user market share analysis, 2022 - 2030
  • Fig. 33 Global Pharmaceutical & Biotechnology Companies market, 2018 - 2030 (USD million)
  • Fig. 34 Global Academic research Institutes market, 2018 - 2030 (USD million)
  • Fig. 35 Global other end-user market, 2018 - 2030 (USD million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 39 U.S. key country dynamics
  • Fig. 40 U.S. microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 41 Canada key country dynamics
  • Fig. 42 Canada microbiome sequencing services market, 2018 - 2030 (USD million)
  • Fig. 43 Europe microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 44 UK key country dynamics
  • Fig. 45 UK microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 46 Germany key country dynamics
  • Fig. 47 Germany microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 48 France key country dynamics
  • Fig. 49 France microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 50 Italy key country dynamics
  • Fig. 51 Italy microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 52 Spain key country dynamics
  • Fig. 53 Spain microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 54 Denmark key country dynamics
  • Fig. 55 Denmark microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 56 Sweden key country dynamics
  • Fig. 57 Sweden microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 58 Norway key country dynamics
  • Fig. 59 Norway microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 60 Asia Pacific microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 61 Japan key country dynamics
  • Fig. 62 Japan microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 63 China key country dynamics
  • Fig. 64 China microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 65 India key country dynamics
  • Fig. 66 India microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 67 Australia key country dynamics
  • Fig. 68 Australia microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 69 Thailand key country dynamics
  • Fig. 70 Thailand microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 71 South Korea key country dynamics
  • Fig. 72 South Korea microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 73 Latin America microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 74 Brazil key country dynamics
  • Fig. 75 Brazil microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 76 Mexico key country dynamics
  • Fig. 77 Mexico microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 78 Argentina key country dynamics
  • Fig. 79 Argentina microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 80 MEA microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 81 South Africa key country dynamics
  • Fig. 82 South Africa microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 83 Saudi Arabia key country dynamics
  • Fig. 84 Saudi Arabia microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 85 UAE key country dynamics
  • Fig. 86 UAE microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 87 Kuwait key country dynamics
  • Fig. 88 Kuwait microbiome sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 89 Key company categorization
  • Fig. 90 Company market positioning
  • Fig. 91 Market participant categorization
  • Fig. 92 Strategy framework